Asset Management
Build Your Comparison
Side-by-side financial analysisStock Comparison
AAMI vs CLSK vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management - Cryptocurrency
Banks - Diversified
AAMI vs CLSK vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||
|---|---|---|---|
| Industry | Asset Management | Asset Management - Cryptocurrency | Banks - Diversified |
| Market Cap | $2.81B | $4.23B | $896.00B |
| Revenue (TTM) | $594M | $740M | $280.33B |
| Net Income (TTM) | $80M | $-501M | $57.05B |
| Gross Margin | 92.9% | 19.2% | 60.0% |
| Operating Margin | 27.4% | -24.5% | 25.9% |
| Forward P/E | 16.4x | 14.7x | 14.4x |
| Total Debt | $323M | $824M | $942.38B |
| Cash & Equiv. | $101M | $43M | $343.34B |
AAMI vs CLSK vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Acadian Asset Manag… (AAMI) | 100 | 630.3 | +530.3% |
| CleanSpark, Inc. (CLSK) | 100 | 636.3 | +536.3% |
| JPMorgan Chase & Co. (JPM) | 100 | 341.0 | +241.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AAMI vs CLSK vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AAMI is the clearest fit if your priority is long-term compounding.
- 471.7% 10Y total return vs JPM's 465.8%
- +148.2% vs JPM's +21.8%
- 11.5% ROA vs CLSK's -16.0%, ROIC 29.2% vs 10.3%
CLSK is the clearest fit if your priority is growth exposure.
- Rev growth 102.2%, EPS growth 262.3%, 3Y rev CAGR 79.9%
- 102.2% revenue growth vs JPM's 3.3%
JPM carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 15 yrs, beta 0.94, yield 1.9%
- Lower volatility, beta 0.94, current ratio 0.52x
- Beta 0.94, yield 1.9%, current ratio 0.52x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 102.2% revenue growth vs JPM's 3.3% | |
| Value | Lower P/E (14.4x vs 14.7x) | |
| Quality / Margins | 20.4% margin vs CLSK's -67.7% | |
| Stability / Safety | Beta 0.94 vs CLSK's 3.62 | |
| Dividends | 1.9% yield, 15-year raise streak, vs AAMI's 0.1% | |
| Momentum (1Y) | +148.2% vs JPM's +21.8% | |
| Efficiency (ROA) | 11.5% ROA vs CLSK's -16.0%, ROIC 29.2% vs 10.3% |
AAMI vs CLSK vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
AAMI vs CLSK vs JPM — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 471.7x AAMI's $594M. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to CLSK's -67.7%.
| Metric | |||
|---|---|---|---|
| RevenueTrailing 12 months | $594M | $740M | $280.3B |
| EBITDAEarnings before interest/tax | $179M | $244M | $81.4B |
| Net IncomeAfter-tax profit | $80M | -$501M | $57.0B |
| Free Cash FlowCash after capex | -$14M | -$1.1B | $100.9B |
| Gross MarginGross profit ÷ Revenue | +92.9% | +19.2% | +60.0% |
| Operating MarginEBIT ÷ Revenue | +27.4% | -24.5% | +25.9% |
| Net MarginNet income ÷ Revenue | +13.5% | -67.7% | +20.4% |
| FCF MarginFCF ÷ Revenue | -2.3% | -144.9% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | -24.9% | — |
| EPS Growth (YoY)Latest quarter vs prior year | -14.2% | -2.1% | +16.0% |
Valuation Metrics
Evenly matched — CLSK and JPM each lead in 3 of 6 comparable metrics.
Valuation Metrics
At 14.7x trailing earnings, CLSK trades at a 59% valuation discount to AAMI's 35.5x P/E. On an enterprise value basis, CLSK's 7.5x EV/EBITDA is more attractive than JPM's 18.4x.
| Metric | |||
|---|---|---|---|
| Market CapShares × price | $2.8B | $4.2B | $896.0B |
| Enterprise ValueMkt cap + debt − cash | $3.0B | $5.0B | $1.50T |
| Trailing P/EPrice ÷ TTM EPS | 35.54x | 14.71x | 16.00x |
| Forward P/EPrice ÷ next-FY EPS est. | 16.38x | — | 14.40x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.90x |
| EV / EBITDAEnterprise value multiple | 16.88x | 7.51x | 18.36x |
| Price / SalesMarket cap ÷ Revenue | 4.72x | 5.52x | 3.20x |
| Price / BookPrice ÷ Book value/share | 33.85x | 2.41x | 2.47x |
| Price / FCFMarket cap ÷ FCF | 15.53x | — | 8.88x |
Profitability & Efficiency
AAMI leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
AAMI delivers a 85.4% return on equity — every $100 of shareholder capital generates $85 in annual profit, vs $-30 for CLSK. CLSK carries lower financial leverage with a 0.38x debt-to-equity ratio, signaling a more conservative balance sheet compared to AAMI's 3.84x. On the Piotroski fundamental quality scale (0–9), AAMI scores 8/9 vs JPM's 5/9, reflecting strong financial health.
| Metric | |||
|---|---|---|---|
| ROE (TTM)Return on equity | +85.4% | -29.9% | +15.9% |
| ROA (TTM)Return on assets | +11.5% | -16.0% | +1.3% |
| ROICReturn on invested capital | +29.2% | +10.3% | +4.5% |
| ROCEReturn on capital employed | +31.9% | +13.7% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 5 | 5 |
| Debt / EquityFinancial leverage | 3.84x | 0.38x | 2.60x |
| Net DebtTotal debt minus cash | $222M | $781M | $599.0B |
| Cash & Equiv.Liquid assets | $101M | $43M | $343.3B |
| Total DebtShort + long-term debt | $323M | $824M | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | 7.60x | -15.45x | 0.74x |
Total Returns (Dividends Reinvested)
AAMI leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AAMI five years ago would be worth $35,390 today (with dividends reinvested), compared to $8,426 for CLSK. Over the past 12 months, AAMI leads with a +148.2% total return vs JPM's +21.8%. The 3-year compound annual growth rate (CAGR) favors CLSK at 63.7% vs JPM's 33.6% — a key indicator of consistent wealth creation.
| Metric | |||
|---|---|---|---|
| YTD ReturnYear-to-date | +66.2% | +42.7% | -0.5% |
| 1-Year ReturnPast 12 months | +148.2% | +69.7% | +21.8% |
| 3-Year ReturnCumulative with dividends | +252.6% | +338.3% | +138.2% |
| 5-Year ReturnCumulative with dividends | +253.9% | -15.7% | +118.2% |
| 10-Year ReturnCumulative with dividends | +471.7% | -82.2% | +465.8% |
| CAGR (3Y)Annualised 3-year return | +52.2% | +63.7% | +33.6% |
Risk & Volatility
Evenly matched — AAMI and JPM each lead in 1 of 2 comparable metrics.
Risk & Volatility
JPM is the less volatile stock with a 0.94 beta — it tends to amplify market swings less than CLSK's 3.62 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AAMI currently trades 99.2% from its 52-week high vs CLSK's 69.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.52x | 3.62x | 0.94x |
| 52-Week HighHighest price in past year | $79.15 | $23.61 | $337.25 |
| 52-Week LowLowest price in past year | $30.98 | $8.00 | $262.71 |
| % of 52W HighCurrent price vs 52-week peak | +99.2% | +69.8% | +95.1% |
| RSI (14)Momentum oscillator 0–100 | 64.4 | 53.9 | 59.1 |
| Avg Volume (50D)Average daily shares traded | 327K | 21.7M | 7.0M |
Analyst Outlook
JPM leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: AAMI as "Hold", CLSK as "Buy", JPM as "Buy". Consensus price targets imply 14.7% upside for CLSK (target: $19) vs -12.6% for AAMI (target: $69). For income investors, JPM offers the higher dividend yield at 1.86% vs CLSK's 0.21%.
| Metric | |||
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $68.67 | $18.90 | $339.75 |
| # AnalystsCovering analysts | 3 | 11 | 61 |
| Dividend YieldAnnual dividend ÷ price | +0.1% | +0.2% | +1.9% |
| Dividend StreakConsecutive years of raises | 0 | 0 | 15 |
| Dividend / ShareAnnual DPS | $0.04 | $0.03 | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.7% | +3.4% | +3.9% |
JPM leads in 2 of 6 categories (Income & Cash Flow, Analyst Outlook). AAMI leads in 2 (Profitability & Efficiency, Total Returns). 2 tied.
AAMI vs CLSK vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is AAMI or CLSK or JPM a better buy right now?
For growth investors, CleanSpark, Inc.
(CLSK) is the stronger pick with 102. 2% revenue growth year-over-year, versus 3. 3% for JPMorgan Chase & Co. (JPM). CleanSpark, Inc. (CLSK) offers the better valuation at 14. 7x trailing P/E, making it the more compelling value choice. Analysts rate CleanSpark, Inc. (CLSK) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AAMI or CLSK or JPM?
On trailing P/E, CleanSpark, Inc.
(CLSK) is the cheapest at 14. 7x versus Acadian Asset Management at 35. 5x. On forward P/E, JPMorgan Chase & Co. is actually cheaper at 14. 4x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — AAMI or CLSK or JPM?
Over the past 5 years, Acadian Asset Management (AAMI) delivered a total return of +253.
9%, compared to -15. 7% for CleanSpark, Inc. (CLSK). Over 10 years, the gap is even starker: AAMI returned +471. 7% versus CLSK's -82. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AAMI or CLSK or JPM?
By beta (market sensitivity over 5 years), JPMorgan Chase & Co.
(JPM) is the lower-risk stock at 0. 94β versus CleanSpark, Inc. 's 3. 62β — meaning CLSK is approximately 284% more volatile than JPM relative to the S&P 500. On balance sheet safety, CleanSpark, Inc. (CLSK) carries a lower debt/equity ratio of 38% versus 4% for Acadian Asset Management — giving it more financial flexibility in a downturn.
05Which is growing faster — AAMI or CLSK or JPM?
By revenue growth (latest reported year), CleanSpark, Inc.
(CLSK) is pulling ahead at 102. 2% versus 3. 3% for JPMorgan Chase & Co. (JPM). On earnings-per-share growth, the picture is similar: CleanSpark, Inc. grew EPS 262. 3% year-over-year, compared to -0. 5% for Acadian Asset Management. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AAMI or CLSK or JPM?
CleanSpark, Inc.
(CLSK) is the more profitable company, earning 47. 6% net margin versus 13. 5% for Acadian Asset Management — meaning it keeps 47. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CLSK leads at 41. 6% versus 26. 0% for JPM. At the gross margin level — before operating expenses — AAMI leads at 92. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AAMI or CLSK or JPM more undervalued right now?
On forward earnings alone, JPMorgan Chase & Co.
(JPM) trades at 14. 4x forward P/E versus 16. 4x for Acadian Asset Management — 2. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CLSK: 14. 7% to $18. 90.
08Which pays a better dividend — AAMI or CLSK or JPM?
In this comparison, JPM (1.
9% yield), CLSK (0. 2% yield) pay a dividend. AAMI does not pay a meaningful dividend and should not be held primarily for income.
09Is AAMI or CLSK or JPM better for a retirement portfolio?
For long-horizon retirement investors, JPMorgan Chase & Co.
(JPM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 94), 1. 9% yield, +465. 8% 10Y return). CleanSpark, Inc. (CLSK) carries a higher beta of 3. 62 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (JPM: +465. 8%, CLSK: -82. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AAMI and CLSK and JPM?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: AAMI is a small-cap high-growth stock; CLSK is a small-cap high-growth stock; JPM is a large-cap deep-value stock. JPM pays a dividend while AAMI, CLSK do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.